Chemiluminescence analysis of drug resistance of the recombinant tissue plasminogen activator

Loading...
Thumbnail Image

Journal Title

Journal ISSN

Volume Title

Publisher

Институт биофизики и клеточной инженерии НАН Беларуси

Editor(s)

Abstract

The aim of this work was to study the biochemiluminescence of blood serum and whole blood in patients who were prescribed rtPA (at a dose of 0.9 mg/kg, the maximum dose was 90 mg) during the first 3 hours after the onset of neurological symptoms (onset of IS).

Description

Citation

Chemiluminescence analysis of drug resistance of the recombinant tissue plasminogen activator / L. V. Batyuk, O. A. Muraveinik, N. N. Kizilova // Современные проблемы клеточной инженерии, иммунологии и аллергологии : международная научная конференция, Минск, 20–21 мая 2021 : сборник тезисов / Институт биофизики и клеточной инженерии НАН Беларуси. – Беларусь, 2021. – С. 58.

Endorsement

Review

Supplemented By

Referenced By